Featured Research

from universities, journals, and other organizations

Scientists aim to put a pox on dog cancer

Date:
September 10, 2012
Source:
University of Illinois at Urbana-Champaign
Summary:
Researchers report that myxoma -- a pox virus that afflicts rabbits but not humans, dogs or any other vertebrates so far studied -- infects several different types of canine cancer cells in cell culture while sparing healthy cells. The study is unique in that it focused on spontaneously occurring cancers in dogs, not induced human cancers in mice.

Illinois veterinarian and pathobiology professor Amy MacNeill and her colleagues discovered that an altered myxoma virus infects and kills dog cancer cells but not healthy cells in cell culture.
Credit: Photo by L. Brian Stauffer

Researchers report that myxoma -- a pox virus that afflicts rabbits but not humans, dogs or any other vertebrates so far studied -- infects several different types of canine cancer cells in cell culture while sparing healthy cells. The study adds to the evidence that viruses or modified viruses will emerge as relatively benign cancer treatments to complement or replace standard cancer therapies.

The new study, reported in the American Journal of Veterinary Research, is unique in that it focused on spontaneously occurring cancers in dogs. This allowed the researchers to avoid a common practice: testing viral therapies on mice or rats with induced human cancers. Such animals must be immunosuppressed to prevent their immune systems from rejecting the foreign tissue, complicating the results.

Treating cancers with viruses could offer several advantages over standard cancer therapies, said University of Illinois veterinarian and pathobiology professor Amy MacNeill, who led the new study. Many cancers have impaired anti-viral defenses, which allow viruses to target tumors while sparing healthy cells. And under the right conditions, infection with an oncolytic (cancer-killing) virus exterminates cancer cells and elicits an anti-cancer immune response without spurring a harmful inflammatory response, she said. Chemotherapy and radiation kill healthy cells along with cancer cells and radiation can cause abrupt cell death that spurs inflammation and pain, she said.

"Ideally, what would happen is the virus would get into a few cancer cells, cause cell death and then spread to the other tumor cells nearby," she said.

Recent studies have shown that oncolytic viral therapies can be used successfully in conjunction with traditional approaches, MacNeill said.

"There was a study in cats where they removed the tumor surgically and then they put a viral therapy in the area where the tumor had been removed," she said. The animals that received the viral therapy had significantly less regrowth of the cancer than those that weren't exposed to the virus after surgery.

"Other studies (1, 2, 3, 4) have shown that once you've eliminated a cancer with an oncolytic virus, if you re-challenge that animal with the same cancer cells, they don't develop tumors," MacNeill said. Viral infection of the cancer cells appears to train the immune system to better recognize the cancer, she said.

In the new study, the researchers wanted to see if spontaneously occurring cancers in dogs were responsive to infection with a virus that is not a pathogen in humans or dogs. They found that cancerous and healthy canine cells respond as human cells do to myxoma infection: The virus invades cancer cells and leaves healthy cells alone. The team also showed that a version of the myxoma virus with a single gene deleted was four times better at killing cancer cells than the unmodified virus. The deleted gene codes for a protein that hinders cell death in infected cells.

More preliminary tests are needed and researchers have many more years of tests and trials ahead, but if all goes well they will eventually test the virus or a modified version of the virus in dogs with cancer, MacNeill said.

"We wanted to make sure that the dog cells were like the human cells because we want to use these viruses not only to cure dogs of cancer but also to use the dogs as better models for humans with cancer," she said. "People are beginning to see the logic of this approach. These dogs have spontaneous tumors just like humans, they're living in the same environment as humans, they're exposed to the same carcinogens in the water if there are any and they sometimes even share our food."

She calls this approach a "win-win" for dogs and humans.

"This way we can test the therapy in dogs while at the same time treating them," she said. "Other researchers can take our results and use them to develop therapies for human patients."

The study team also included researchers from the University of Florida.


Story Source:

The above story is based on materials provided by University of Illinois at Urbana-Champaign. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ashlee S. Urbasic, Stacy Hynes, Amy Somrak, Stacey Contakos, Masmudur M. Rahman, Jia Liu, Amy L. MacNeill. Oncolysis of canine tumor cells by myxoma virus lacking the serp2 gene. American Journal of Veterinary Research, 2012; 73 (8): 1252 DOI: 10.2460/ajvr.73.8.1252

Cite This Page:

University of Illinois at Urbana-Champaign. "Scientists aim to put a pox on dog cancer." ScienceDaily. ScienceDaily, 10 September 2012. <www.sciencedaily.com/releases/2012/09/120910143410.htm>.
University of Illinois at Urbana-Champaign. (2012, September 10). Scientists aim to put a pox on dog cancer. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2012/09/120910143410.htm
University of Illinois at Urbana-Champaign. "Scientists aim to put a pox on dog cancer." ScienceDaily. www.sciencedaily.com/releases/2012/09/120910143410.htm (accessed October 21, 2014).

Share This



More Plants & Animals News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

White Lion Cubs Born in Belgrade Zoo

White Lion Cubs Born in Belgrade Zoo

AFP (Oct. 20, 2014) Two white lion cubs, an extremely rare subspecies of the African lion, were recently born at Belgrade Zoo. They are being bottle fed by zoo keepers after they were rejected by their mother after birth. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Traditional Farming Methods Gaining Ground in Mali

Traditional Farming Methods Gaining Ground in Mali

AFP (Oct. 20, 2014) He is leading a one man agricultural revolution in Mali - Oumar Diatabe uses traditional farming methods to get the most out of his land and is teaching others across the country how to do the same. Duration: 01:44 Video provided by AFP
Powered by NewsLook.com
Goliath Spider Will Give You Nightmares

Goliath Spider Will Give You Nightmares

Buzz60 (Oct. 20, 2014) An entomologist stumbled upon a South American Goliath Birdeater. With a name like that, you know it's a terrifying creepy crawler. Sean Dowling (@SeanDowlingTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Adorable Video of Baby Rhino and Lamb Friend Playing

Adorable Video of Baby Rhino and Lamb Friend Playing

Buzz60 (Oct. 20, 2014) Gertjie the Rhino and Lammie the Lamb are teaching the world about animal conservation and friendship. TC Newman (@PurpleTCNewman) has the adorable video! Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins